06-Apr-17 Global healthcare spending is roughly USD7 tn, according to the US Department of Commerce and many companies would have more success pursuing product approval in emerging markets as the technologies may be more helpful for those patient populations and the regulatory burdens more manageable, suggested Matthew Hein, representative for the US DoC at the MedTech Intelligence Global Regulatory conference. [image: MedTech Intelligence]

06-Apr-17 Korea's medical institutions expanded their businesses into 20 countries during 2016, according to a report by the Ministry of Health & Welfare. During 2016, Korean medical institutions continued their spread of the medicalss "Korean wave”, entering countries including China, the USA, Vietnam, Kazakhstan, and the UAE as well as many others, three more countries than in 2015. [image: Business Korea]

04-Apr-17 The American medical deep learning company Enlitic has agreed to cooperate with healthcare big data company Beijing Hao Yun Dao Information & Technology ("Paiyipai") to provide diagnostic imaging in Health Check centers across China. The partnership was agreed following a successful 10,000 chest x-ray trial of Enlitic's patient triage platform. [image: Enlitic]

27-Mar-17 Ericsson has partnered with China Mobile and AstraZeneca to connect healthcare equipment using NB-IoT technology. China Mobile’s Jiangsu branch and Ericsson will work together to trial new applications using cellular IoT technologies like NB-IoT and provide network terminal management to support equipment management. Additionally, AstraZeneca is also working with the Wuxi government to open a China Commercial Innovation Center. [image: Wireless Week / Ericsson].

31-Mar-17 Without much press or international recognition, Chinese companies have been making good progress enhancing their pharmaceutical and healthcare prowess. For example, in the past few years, 50+ Chinese pharmaceutical companies have entered or completed phase I and phase II clinical trials, while 10+ companies have completed phase III trials. [image: China Money Network